Abatacept
Severe
Database
Clinical effect not specified
Source: DDInter
Drug reference
satralizumab
IL-6 receptor antibody · Immunosuppressant
IL-6 receptor antibodyImmunosuppressant
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 12 →
- AbataceptSevereDatabaseDDInter
- AdalimumabSevereDatabaseDDInter
- AnakinraSevereDatabaseDDInter
- BaricitinibSevereDatabaseDDInter
Mechanism
Antibody to IL-6R.
Indications
treatment of neuromyelitis optica spectrum disorder in adult patients who are positive for anti–aquaporin-4 antibody
Contraindications
- live vaccines (avoid with il-6 blockade)
Side effects
Serious
- increased risk of serious infections
- serious cases of hepatoxicity
Drug interactions
Adalimumab
Severe
Database
Drug interaction classified as: others
Source: DDInter
Anakinra
Severe
Database
Drug interaction classified as: others
Source: DDInter
Baricitinib
Severe
Database
Drug interaction classified as: others
Source: DDInter
Canakinumab
Severe
Database
Drug interaction classified as: others
Source: DDInter
Certolizumab
Severe
Database
Drug interaction classified as: others
Source: DDInter
Cladribine
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Clozapine
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Deferiprone
Severe
Database
Clinical effect not specified
Source: DDInter
Etanercept
Severe
Database
Drug interaction classified as: others
Source: DDInter
Fingolimod
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Golimumab
Severe
Database
Clinical effect not specified
Source: DDInter
Related guidelines
Hypertensive disorders of pregnancy
FOGSI · Obstetrics & Gynaecology · 2019
Substance use disorders
NIMHANS · Psychiatry · 2022
Alcohol use disorder
MOHFW · Psychiatry · 2021
Generalised anxiety disorder and panic disorder
NICE · Psychiatry · 2020
Chronic kidney disease — mineral and bone disorder
KDIGO · Nephrology · 2017
Ask House about satralizumab
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team